New Market Research Report: HTG Molecular Diagnostics, Inc. - Product Pipeline Analysis, 2014 Update

Boston, MA -- (SBWIRE) -- 10/22/2014 -- HTG Molecular Diagnostics, Inc. (HTG) is a technology service provider. The company provides molecular-technology solutions. It provides services to biomarker discovery and companion diagnostic developers. The company's HTG Molecular Diagnostics EDGE system offers extraction-free gene expression results from FFPE tissue samples. HTG develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. The company provides extraction-free gene expression profiles that can measure miRNA and mRNA from source material for diagnostic applications. It also provides endogenous control array, custom array development, qSelect miRNA gene list, qSelect mRNA gene list, qDiscovery miRNA Version 16, clinical trial support, and ingenuity IPA data analysis services to pharmaceutical clients. HTG is headquartered in Tucson, Arizona, the US.